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INTRODUCTION
The antitumor effect of not only BCG and some other mycobacteria including M. tuber-
culosis1,2), M. kansasii) M. smegmatis3 ) , M. butyricum 4 - 6), but also other organisms such
as Nocardia asteroides) N. rubra) Corynebacterium diphtheriae 7 ) or its toxin8), anaerobic
corynebacteria9- 14), Bordetella pertussis15 ,17), or even some protozoaI8 ,19) has been reported.
The mechanism of the action of these organisms is still a matter of speculation and may be
different by agents 8). But, in most cases, the action seems to reflect a generlaized stimulation
of phagocytes and the activation of reticuloendothelial systeml ,12,20,21), resulting in the
production of serum antibodies and delayed hypersensitivity reactions 22).
However, none seems to have studied the possibility of tumor suppression with Myco-
bacterium lepraemurium which is non-pathogenic to humans; one of the reasons may be that
lesions experimentally produced by this organism in animals is analogous to the lepromatous
lesions in humans and lepromin reactions with this organism do not appear, which suggests
that cellular immunity may not be induced in the hosts.
The present work was undertaken (a) to study the effects of live or heat-killed murine
leprosy bacilli on the spontaneous mammary tumors in mice, and (b) to know whether the tumor
suppression, if any, would accompany the murine lepromin reaction.
MATERIALS AND METHODS
Organisms used. Mycobacterium lepraemurium Hawaii strain was inoculated into C3H
mice intraperitoneally. They were sacrificed 4 to 6 months later, and enlarged liver and spleen
were resected aseptically. The organs were cut into pieces, added with 5 volumes of 0.2°;6
trypsin phosphate buffer and digested for 2 hrs at 37°C, and homogenized in Teflon glass homo-
gemzer. In order to remove undigested organ debris, the suspension was added with 2 volumes
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of phosphate buffer and centrifuged at 1,000 rpm for 10 minutes. The supernatant was then
centrifuged at 4,000 rpm for 30 minutes. The sediment was again added with phosphate
buffer and centrifuged. This procedure was repeated more than 6 times. The sediment finally
obtained was composed solely of acid-fast bacilli and no organ debris was found by Ziehl-Neelsen
stain. The sediment was added with phosphate buffer, and appropriate bacillus concentrations
were obtained by counting the number of the bacilli using hemocytometer. These suspensions
will be referred to as living M. lepraemurium (LMlm). When LMlm was heated at 100°C
for 30 minutes, they will be referred to as heat-killed M. lepraemurium (HKMlm). Both
suspensions were stored at -20°C and used within 4 months after preparation.
In some cases equal volume of Freund's incomplete adjuvant (FIA) was added to LMlm
or HKMlm and converted to water-in-oil emulsion by Waring blender (LMlm+FIA, or
HKMlm+FIA). One tenth ml of the desired bacillus concentration of the preparation was
injected into mice intraperitoneally.
Murine lepromin tests (MLT). 107 living cells of M. lepraemurium suspended in 0.025
ml phosphate buffer were heated at 100°C for 30 minutes. Right footpad of mice was injected
with 0.025 ml of this suspension. The thickness of both footpads was measured by dial-gauged
calipers (Mitsutoyo, Japan) at 48 hrs (early reaction), 1,2,3,4, and, in one experiment, 5 weeks
(late reactions) after injection. The calipers employed can measure up to 0.005 mm. The
thickness of right footpad after substracting that of left footpad (control) will be referred to
as the value of MLT.
Animals. C3H/He female mice obtained from Animal Center of Kyoto University were
used. The mice within two weeks difference in age were divided into groups randomly, in-
cluding one untreated group, in a series of experiments. CMF pellets (Oriental Yeast Co.,
LTD) and tap water were given ad. lib.
Examinatz'on of tumors. All mice were examined tumor incidence by inspection once
a week. In cases when LMlm was injected, all the tumors produced were biopsied and the
smears were stained with Ziehl-Neelsen and Giemsa-May-Griinwald stain. No tumors ever
contained acid-fast bacilli. At death the weight of liver and spleen were measured. The
smears of liver and spleen were also stained with Ziehl-Neelsen and Giemsa-May-Griinwald
stains.
RESULTS
In the first experiment sixty C3H/He female mice were divided into five groups; ten each
of first two groups were given with 108 LMlm or 10 8 LMlm+FIA, respectively, at the age of
19 week. The mice of group 3 were injected with HKMlm 3 times at the age of 19, 29, and 36
week in the dose of 10 8, 3 X 10 7, and 108, respectively; and ten mice of group 4 were given the
same inocula at the same age as group 3 except that the first injection was 108 HKMlm+FIA.
The remaining 20 mice were served as the untreated controls. Observation was made until
60 weeks of age. Results are summarized in Table l.
As seen in the table, when 108 LMlm were injected (group 1), four mice died of murine
leprosy before producing tumors. Spontaneous mammary tumor was produced in all the
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Table. 1 Incidence of spontaneous mammary tumor in C3HjHe female mice within 60 weeks
of age (Experiment 1)
No. of mice TTFF4) MTAT±SD5)
Group Treatment Used FT1) DML2) T3) (weeks) (weeks)
1 LMlm 10 0 4 6 27 36.6± 6.24
2 LMlm+FIA 10 0 1 9 26 40.1::t 7.89
3 HKMlm 10 0 0 10 32 41. 3± 5.81
4 HKMlm+FIA 10 3 0 7 33 46.7± 9.43
and HKMlm
5 Control 20 0 0 20 23 38. 3±10. 48
1) Free from tumor at 60 weeks of age.
2) Died of murine leprosy before tumor appearance.
3) Produced tumor.
4) Time when tumor was first found.
5) Mean tumor appearance time±Standard cleviation.
remammg 6 mIce. Tumor was first observed at 27 weeks of age. The mean age of tumor
incidence of these 6 mice was 36.6±6.24 weeks which shows little difference from that of the
control, 38.3±10.48.
In group 2 where 108 LMlm plus FIA was injected, only one mouse died of murine leprosy,
and all the remaining 9 mice produced tumors, the first incidence of tumor and the mean age
of tumor appearance being 26 and 40.1±7.89 weeks, respectively. This also indicates that
no tumor suppression was seen. It should be mentioned here that lepromatous lesions in the
liver were not marked and the swelling of spleen was clearly reduced in these 9 mice compared
with those infected with LMlm alone.
When HKMlm was injected 3 times (group 3), the first incidence of tumor was at 32 weeks
of age which was 9 weeks later than 23 weeks of the control. However, tumor suppression
was not observed thereafter; and the mean age of tumor appearance was 41.3±5.81 weeks.
When the first inoculum was replaced by HKMlm plus FIA instead of HKMlm (group
4), a difinite tumor suppression was observed. The first tumor incidence in this group was 33
weeks of age which was 10 weeks later than that of the control, and 3 mice were free from tumor
even at 60 weeks of age. Fig. 1 shows the cummulative frequencey of tumor in groups 4 and
5 (control).
MLT was performed in the first four groups at 40 weeks of age. Fig. 2 shows the average
]\tILT values at different times after the test. No clear reaction was observed in LMlm group
up to 5 weeks after the test. In LMlm+FIA group slight early and late reactions were observed.
On the contrary, both early and late reactions were clearly obtained in groups of both HKMlm
and HLMlm + FIA; especially the late reaction was observed clearly as early as 2 weeks after
the test in HKMlm+FIA group.
In the second experiment 36 mice were divided equally into three groups. The first group
of mice were given with 106 LMlm at the age of 6 week, the second group was administered
7 times with HKMlm at the age of 6, 11, 16, 21, 26, 32, and 37 week. The dose of the first

















Fig. 1 Cummulative frequency of spontaneous mammary tumor in C3HjHe
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Fig. 2 Murine lepromin test values in Experiment 1
Table. 2 Incidence of spontaneous mammary tumor in C3HjHe female mice within 50 weeks
of age (Experiment 2)
No. of mice TTFP)
Group Treatment Used FT1) DML2) T3) (weeks)
_•... _----_.-
1 LM1m 12 0 6 6 27
2 HKM1m 12 8 0 4 32
3 Control 12 3 0 9 25
1) Free from tumor at 50 weeks of age.
2) Died of murine leprosy before tumor appearance.
3) Produced tumor.
4) Time when tumor was first found.
injection was 10 6, but that of the others was 107 • The third group of mice were served as con-
trols. Observation was made until 50 weeks of age.
The results are shown in Table 2. When LMlm was injected (group 1), SIX mIce (50%)
died of murine leprosy before tumor appearance, and all the remaining mice produced tumors.
However, when HKMlm was injected 7 times (group 2), tumor was first observed at 32 weeks
of age which was 7 weeks later than 25 weeks of the control group, and only four mice (33%)
























Fig. 3 Cummulative frequency of spontaneous mammary tumor in C3H/lle



















Fig. 4 Murine lepromin test values in Experiment 2
produced tumors in contrast to nine (750/0) in the control group. In Fig. 3 cummulative
frequency of tumor of this group is compared with that of the control.
Fig. 4 shows the results of MLT of these three groups performed at the age of 27 week.
In the untreated control 48 hr value was weak, but 2 weeks and thereafter the reaction became
stronger reaching maximum at 4 weeks. In LMlm group the reactions were weak throughout
the observation as were the case in the first experiment. On the contrary, the characteristic
feature of HKMlm group was that very strong late reaction was obtained as early as 2 weeks
which was comparable to the maximum value observed at 4 weeks in the control group. It
should also be noted that in this group the difference in values was not observed between tumor-
bearing and non-hearing mice.
DISCUSSION
It was shown in the present experiments that LMlm, even though given in different doses
at different ages and whether with or without FIA, had no effect in suppressing the spontaneous
mammary tumor of mice. Moreover, as the organism is pathogenic for mice, some mice died
of murine leprosy before tumor incidence and MLT was faint. The only interesting finding
in the case of LMlm was that in LMlm+ FIA group fewer mice died of leprosy and the lepro-
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matous lesions were less severe than LMlm alone group. This finding recalls us the work
of Uyeda et al. (23) who found that mortality of mice infected with virulent tubercle bacilli
H37Rv (human type) or Ravenel (bovine type) mixed with paraffin oil was much less than that
given with water suspensions of these organisms. They explained the fact that the organisms
in oil were prevented from ingestion by phagocytes in which the bacilli can multiply. Whether
the same is true in the case of murine leprosy bacilli or not remains to be studied.
The most striking feature of the present work was the retardation and decrease of tumor
appearance in mice repeatedly treated with HKMlm. In this case the age of mice and
frequency of treatment seem to influence the effect of HKMlm. In comparison with the results
of group 3 in Table 1 and group 2 in Table 2, it may be said that stronger tumor suppression
will be obtained if the treatment begins in younger age and repeats more frequently. Freund's
incomplete adjuvant seems to aid the effect of HKMlm.
I t should be noted that strong murine lepromin reactions, especially late reactions, were
observed by the repeated HKMlm injections. This indicates that the ability to suppress the
incidence of spontaneous mammary tumor in mice has some relation to the positive conversion
of murine lepromin reaction which is said to be an expres8ion of cellular immunity. However,
as there was no difference in MLT values in tumor-bearing and non-bearing mice in HKMlm
group in the second experiment, cellular immunity alone seems not enough to suppress mammary
tumors.
SUMMARY
When heat-killed Mycobacterium lepraemurium} with or without Freund's incomplete
adjuvant, was injected intraperitoneally into C3HJHe female mice repeatedly, incidence of
spontaneous mammary tumor was retarded or suppressed. The murine lepromin reactions,
especially late reactions, became stronger by this treatment. Freund's incomplete adjuvant
seems to aid the effect of heat-killed bacilli. Live cells of Mycobacterium lepraemurium} with
or without the adjuvant, had no tumor suppressing effect and the murine lepromin reactions
were weak.
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